Back to Search
MURALI CHINTAGUMPALA, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1386724714Individual
Specialties, Licenses & Credentials
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
J1635(TX)
Research & Publications (20)
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
PMID 18796696·Neuro Oncol·2009
4-observational
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
PMID 16314955·J Neurooncol·2006
3-trial
Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.
PMID 15514381·J Clin Oncol·2004
3-trial
Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
PMID 18501529·Int J Radiat Oncol Biol Phys·2009
3-trial
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.
PMID 19653709·Arch Pathol Lab Med·2009
8-other
Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma.
PMID 18485616·Int J Radiat Oncol Biol Phys·2009
3-trial
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
PMID 18952980·Neuro Oncol·2009
8-other
Acquired von Willebrand syndrome and Wilms tumor: not always benign.
PMID 19006222·Pediatr Blood Cancer·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 FANNIN ST
HOUSTON, TX 77030 - Phone
- (832) 822-4240
Quick Facts
- NPI
- 1386724714
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile